MOH Molina Healthcare, Inc.

QT77

NYSE·Healthcare·Medical - Healthcare Plans·USA

Latest market price

207.85

-0.60-0.29%

Overview Short InterestFilings

MOHQT77Molina Healthcare, Inc.·NYSE

Overview Short InterestFilings

207.85-0.29%

Loading chart...

Signal & projected range

Analyst consensus risingHistorical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

OSCR+4.55%$32.41 CNC+1.43%$67.48 HUM+1.82%$417.87 CLOV-0.46%$4.29 PGNY-1.19%$29.06 CI+0.08%$295.44 ALHC+5.57%$7.39 ELV+0.04%$413.75

Snapshot

Index	—	P/E	—	EPS (ttm)	-0.57	Insider Own	1.65%	Shs Outstand	52.20M	Perf Week	4.21%

Market Cap	10.88B	Forward P/E	21.51	EPS next Y	9.69	Insider Trans	-2.13%	Shs Float	47.88M	Perf Month	7.11%

Enterprise Value	6.25B	PEG	—	EPS next Q	0.56			Short Float	6.25%	Perf Quarter	6.51%

Income	-48.00M	P/S	0.25	EPS this Y	-62.21%			Short Ratio	3.35	Perf Half Y	8.16%

Sales	43.63B	P/B	2.62	EPS next Y	84.27%	ROA	-0.31%	Short Interest	2.99M	Perf YTD	19.77%

Book/sh	79.60	P/C	1.27	EPS next 5Y	48.90%	ROE	-1.17%	52W High	244.89 -15.13%	Perf Year	35.80%

Cash/sh	164.35	P/FCF	45.72	EPS past 3/5Y	-12.99% -4.52%	ROIC	2.08%	52W Low	121.06 71.69%	Perf 3Y	-38.16%

Dividend Est.	—	EV/EBITDA	18.78	Sales past 3/5Y	12.42% 18.52%	Gross Margin	8.06%	Volatility	4.06% 4.54%	Perf 5Y	-30.59%

Dividend TTM	—	EV/Sales	0.14	EPS Y/Y TTM	-103.55%	Oper. Margin	0.39%	ATR (14)	9.07	Perf 10Y	248.74%

Dividend Ex-Date	—	Quick Ratio	1.69	Sales Y/Y TTM	-2.07%	Profit Margin	-0.11%	RSI (14)	54.15	Recom	2.72

Dividend Gr. 3/5Y	—	Current Ratio	1.69	EPS Q/Q	-51.63%	SMA20	0.81%	Beta	0.71	Target Price	216.73

Payout	0.00%	Debt/Eq	0.95	Sales Q/Q	-7.80%	SMA50	3.44%	Rel Volume	1.43	Prev Close	208.45

Employees	19,000	LT Debt/Eq	0.95	Earnings	Feb 04	SMA200	12.31%	Avg Volume	718.96K	Price	207.85

IPO Date	Jul 02, 2003	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.69% 2.09%	Net Debt/EBITDA	-13.90	Volume	1,031,542	Change	-0.29%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Oct-26-26	Reiterated	Deutsche Bank	Hold	$147 → $163
Oct-23-26	Reiterated	Robert W. Baird		$163 → $198
Oct-23-26	Reiterated	Mizuho Securities	Outperform	$215 → $255
Oct-23-26	Reiterated	Jefferies	Hold	$230 → $220
Oct-23-26	Reiterated	UBS	Neutral	$202 → $225
Oct-23-26	Reiterated	RBC Capital	Sector Perform	$218 → $222
Oct-23-26	Reiterated	Barclays	Underweight	$180 → $178
Jul-28-26	Reiterated	Wells Fargo	Equal Weight	$235 → $220
Jul-24-26	Reiterated	Barclays	Underweight	$184 → $180
Jul-24-26	Reiterated	RBC Capital	Sector Perform	$248 → $218

Latest News· Times ET

Oct-29-26

Oct-29-2606:20PM

Molina: 3 Key Takeaways for Long-Term InvestorsYahoo

Oct-26-26

Oct-26-2601:59PM

How Much Should This Move Change Your View Of Centene Stock?Yahoo

Oct-22-26

Oct-22-2605:05PM

Molina Healthcare Q3 Earnings Call Highlightsmarketbeat.com

04:57PM

Molina Healthcare, Inc. (MOH) Q3 2026 Earnings Call Transcriptseekingalpha.com

Oct-21-26

Oct-21-2608:51PM

Molina (MOH) Surpasses Q3 Earnings and Revenue Estimateszacks.com

07:31PM

Molina (MOH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimateszacks.com

04:15PM

Molina Healthcare Reports Third Quarter 2026 Financial Resultsbusinesswire.com

08:30AM

How Artificial Intelligence Is Reshaping Preventive Care Across the U.S.globenewswire.com

Oct-20-26

Oct-20-2610:16AM

What Analyst Projections for Key Metrics Reveal About Molina (MOH) Q3 Earningszacks.com

Oct-18-26

Oct-18-2604:30AM

Earnings Volatility Watch: Bloom Energy and Other 11 Stocks Are Priced For Double-Digit SwingsBenzinga

Oct-16-26

Oct-16-2601:46PM

Can Molina Healthcare Overcome Lower Premiums and Higher MCR in Q3?zacks.com

12:20PM

Oscar Health vs. Molina: Which Healthcare Stock Is a Better Buy?zacks.com

Oct-14-26

Oct-14-2611:01AM

Analysts Estimate Molina (MOH) to Report a Decline in Earnings: What to Look Out forzacks.com

Oct-12-26

Oct-12-2611:37AM

Centene vs. Molina: Which Managed Care Stock Has More Upside?Yahoo

Oct-05-26

Oct-05-2601:38PM

Oscar Health Trading at a Premium: Why Should You Still Buy It?Yahoo

Company

Molina Healthcare, Inc. offers comprehensive managed health care services, primarily targeting economically disadvantaged families and individuals. The company provides coverage through key government initiatives such as Medicaid and Medicare programs, in addition to state health insurance marketplaces. Its operations are strategically segmented into four main divisions: Medicaid, Medicare, Marketplace, and a general "Other" category. By the close of 2021, specifically December 31st, Molina Healthcare's network extended to approximately 5.2 million members across 18 states, all of whom qualified for Medicaid, Medicare, or other government-sponsored healthcare plans. Established in 1980, the company maintains its corporate headquarters in Long Beach, California.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	43,627	45,426	40,650	34,072	—	—	—	—	—
Cost of Goods Sold Incl. D&A	40,112	41,351	35,914	29,738	—	—	—	—	—
Gross Profit	3,515	4,075	4,736	4,334	—	—	—	—	—
Selling, General and Administrative Excl. Other	3,008	3,009	2,743	2,462	—	—	—	—	—
Research and Development	0	0	0	0	—	—	—	—	—
Other Operating Expense	335	285	286	299	—	—	—	—	—
Operating Income	172	781	1,707	1,573	—	—	—	—	—
Interest Expense	213	192	118	109	—	—	—	—	—
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	0	0	0	0	—	—	—	—	—
Net Income Before Taxes	-41	589	1,589	1,464	—	—	—	—	—
Income Taxes	7	117	410	373	—	—	—	—	—
Consolidated Net Income	-48	472	1,179	1,091	—	—	—	—	—
Net Income From Continuing Operations	-48	472	1,179	1,091	—	—	—	—	—
Net Income	-48	472	1,179	1,091	—	—	—	—	—
EPS (Recurring)	-0.61	8.93	20.52	18.71	—	—	—	—	—
EPS (Basic, Before Extraordinaries)	-0.61	8.93	20.52	18.71	—	—	—	—	—
EPS (Diluted)	-0.57	8.92	20.42	18.78	—	—	—	—	—
EBITDA	333	976	1,893	1,744	—	—	—	—	—
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	—	19.46	14.25	19.24	—	—	—	—	—
Price To Sales Ratio	0.25	0.19	0.41	0.62	—	—	—	—	—
Gross Margin	8.06	8.97	11.65	12.72	—	—	—	—	—
Operating Margin	0.39	1.72	4.20	4.62	—	—	—	—	—
Net Margin	-0.11	1.04	2.90	3.20	—	—	—	—	—
Shares Outstanding	52	51	57	58	—	—	—	—	—
Market Capitalization	10,808	8,851	16,590	20,956	—	—	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
HEBERT MAURICE	Chief Accounting Officer	May 14 '26	Sale	191.55	600	114,930	12,815	May 15
Barlow Jeff D.	Chief Legal Officer	May 11 '26	Sale	186.12	17,811	3,314,983	67,175	May 13
ROMNEY RONNA	Director	Mar 12 '26	Sale	146.92	506	74,342	17,227	Mar 13
ZORETIC RICHARD C	Director	Feb 11 '26	Buy	125.16	800	100,128	8,747	Feb 12
Schapiro Richard M	Director	Nov 24 '25	Sale	143.02	357	51,058	11,352	Nov 24
ROMNEY RONNA	Director	Aug 06 '25	Sale	153.74	700	107,618	17,131	Aug 08
WOYS JAMES	Chief Operating Officer	Aug 04 '25	Buy	155.94	10,000	1,559,365	74,331	Aug 06
WOLF DALE B	Director	May 21 '25	Sale	322.89	1,500	484,328	14,209	May 22
ORLANDO STEVEN J	Director	May 05 '25	Sale	318.58	1,000	318,580	16,543	May 05
Zubretsky Joseph M	President & CEO	Apr 30 '25	Sale	320.06	87,500	28,005,170	257,715	May 02
Schapiro Richard M	Director	Apr 29 '25	Sale	320.50	669	214,415	11,244	May 01
ORLANDO STEVEN J	Director	Mar 03 '25	Sale	301.33	1,000	301,330	17,375	Mar 04
Schapiro Richard M	Director	Nov 18 '24	Sale	292.72	136	39,810	11,556	Nov 19
HEBERT MAURICE	Chief Accounting Officer	Aug 15 '24	Sale	346.52	393	136,182	9,473	Aug 16
ORLANDO STEVEN J	Director	Jul 30 '24	Sale	339.21	1,000	339,210	18,025	Jul 30

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.